HerbalScience Nutraceuticals Secures Capital Investment

NAPLES, Fla.—Botanical extract developer HerbalScience Nutraceuticals LLC completed a convertible preferred unit transaction with Aisling Capital and Weston Presidio, two leading private equity firms. HerbalScience develops advanced, proprietary and environmentally friendly extraction technology to produce whole botanical extracts for use in functional food and beverage and nutraceutical brands. According to the company, the extracts maintain the natural synergy of a plant’s chemical makeup while enhancing its medicinal effectiveness.

Robert Gow, founder and chairman of HerbalScience (www.HerbalScienceGroup.com), noted Aisling Capital and Weston Presidio have significant life sciences and consumer product experience, which will significantly enhance the HerbalScience business. “The infusion of new capital will enable HerbalScience to expand its production facilities to meet the growing global market demand for its science-based and proven-effective, functional ingredients,” he said.